Efficacy and safety of iodine-125 seed implantations combined with chemotherapy and immunotherapy for patients with non-small cell lung cancer: protocol for a systematic review and meta-analysis
Background Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality worldwide, with conventional treatments often limited by radiation resistance, systemic toxicity and poor outcomes in advanced stages. Iodine-125 (I-125) seed implantation, combined with chemotherapy and imm...
Saved in:
| Main Authors: | Hao-yu Zhang, Kuanghao Wu, Hong-yan Zheng, Xin-yu Song |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-04-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/4/e094632.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dose and local efficacy analysis of iodine-125 seed implantation therapy for lung tumors
by: Guohui Cao, et al.
Published: (2025-06-01) -
Efficacy and safety of anlotinib combined with 125I seed implantation for iodine-refractory thyroid cancer
by: Zhijun Chen, et al.
Published: (2025-08-01) -
Meta-analysis of clinical efficacy and safety of immunotherapy combined with chemotherapy in non-small cell lung cancer
by: Zhu Wugang, et al.
Published: (2025-08-01) -
A Meta‐Analysis of Efficacy and Safety of Neoadjuvant Immunotherapy Plus Chemotherapy for Resectable Non‐Small Cell Lung Cancer
by: Xinru Sun, et al.
Published: (2024-10-01) -
Nomogram prediction model for overall survival of late-stage lung cancer patients undergoing iodine-125 particle implantation brachytherapy
by: Tingting Ding, et al.
Published: (2024-12-01)